IBC Life Sciences announces a partnership with BayHelix Group to co-organize the 6th Annual China Pharmaceutical R&D Summit, taking place on April 11-13, 2011 in Shanghai, China.
The BayHelix Group, an organization of leaders of Chinese heritage in the global life sciences and healthcare community, has been a strong supporter of IBC's China Pharmaceutical R&D Summit for the past five years, and the relationship between the two companies has solidified to today's co-development and co-organization of the 6th Annual event.
"IBC's goal is to be the bridge between life sciences communities on both the Eastern and Western parts of the world. We encourage individuals to explore business opportunities and develop their international networks. Our conferences help attendees share their innovative ideas for new drugs to address unmet medical needs. This fits in perfectly with BayHelix's mission and aspirations, and together, we feel we'll be able to bring the information sharing spirit and the networking opportunities to an even broader audience," explained Mimi Langley, Conference Producer, IBC Life Sciences.
"BayHelix is pleased to have the opportunity to partner with IBC for making the annual summit an even more effective setting for global R&D leaders to exchange ideas and create business opportunities. The number of life science related meetings in China has been proliferating, reflecting the tremendous growth potential in the sector. Our members at BayHelix and staff at IBC are working hard to ensure the IBC-BayHelix China Pharmaceutical R&D Summit remains as the preferred venue for people to share their experience and wisdom on the fast evolving R&D landscape in China," commented Tony Zhang, Chairman of BayHelix.